Suprastinex drops 5mg / ml, 20 ml

Symptomatic treatment of the following conditions:

perennial (persistent) and seasonal (intermittent) allergic rhinitis and conjunctivitis (itching, sneezing, rhinorrhea, lacrimation, conjunctival hyperemia);

hay fever (hay fever);

urticaria, incl. chronic idiopathic urticaria;

Quincke's edema;

allergic dermatoses, accompanied by itching and rashes.

Inside, during meals or on an empty stomach, with a little water without chewing. To take the drug in the form of drops, use a teaspoon. If necessary, the dose of the drug can be diluted in a small amount of water immediately before use.

It is recommended to take the daily dose at one time.

The recommended dose for adults and children over 6 years old, elderly patients (subject to normal renal function) is 5 mg (1 tab. Or 1 ml (20 drops from a dropper) per day).

The maximum daily dose should not exceed 5 mg

Children aged 2 to 6 years - the daily recommended dose is 2.5 mg (10 drops) for 2 doses in equal doses of 1.25 mg (2 times 0.25 ml drops or 2 times 5 drops from a dropper) ...

The maximum daily dose should not exceed 2.5 mg.

Patients with impaired renal function. The frequency of administration should be set individually in accordance with renal function. In patients with chronic renal failure with Cl creatinine from 30 to 49 ml / min, the dose should be reduced by 2 times - 5 mg each (1 tab. Or 1 ml (20 drops) every other day; with Cl creatinine from 10 to 29 ml / min, the dose must be reduced 3 times - 5 mg each (1 table. or 1 ml (20 drops) every 3 days. In end-stage renal failure (Cl creatinine less than 10 ml / min), the drug is contraindicated.

The creatinine clearance for men can be calculated based on the concentration of serum creatinine, according to the following formula: Cl creatinine, ml / min = (140? Age, years)? body weight, kg / 72? Cl serum creatinine, mg / dl

Cl creatinine for women can be calculated by multiplying the resulting value by a factor of 0.85.

Patients with impaired liver function. When prescribing the drug to patients with isolated liver dysfunction, no dose changes are required. For patients with concomitant impairment of liver and kidney function, dose adjustment is recommended (see Patients with impaired renal function above).

Duration of taking the drug. The duration of admission depends on the disease.

For persistent allergic rhinitis (symptoms <4 days / 1 week or lasting less than 4 weeks), treatment is continued until symptoms resolve; if symptoms occur, treatment can be resumed. When treating seasonal (intermittent) allergic rhinitis (symptoms> 4 days / 1 week or lasting more than 4 weeks), treatment is continued for the entire period of exposure to allergens.

The course of treatment for pollinosis is determined by the doctor; on average, it is 1Ц6 weeks.

There is clinical experience with the drug lasting up to 6 months.

hypersensitivity to the active substance (including piperazine derivatives) or any auxiliary component of the drug;

end stage renal failure (Cl creatinine less than 10 ml / min);

children under 6 years of age (for film-coated tablets) and up to 2 years (for oral drops) - due to lack of clinical data;

pregnancy and lactation (see 'Application during pregnancy and lactation');

lactose intolerance, hereditary lactase deficiency or glucose-galactose malabsorption syndrome - for film-coated tablets (see 'Special instructions').

With care: chronic renal failure (correction of the dosage regimen is necessary); elderly people (with age-related decrease in glomerular filtration); patients with spinal cord injury, prostatic hyperplasia, as well as in the presence of other predisposing factors to urinary retention, since levocetirizine may increase the risk of urinary retention; simultaneous use with alcohol (see 'Interaction').